Oncology & Cancer
Study identifies causes of cancer
A team of Yale-led researchers can now quantify the factors causing changes in the DNA that contribute most to cancer growth in tumors of most major tumor types.
Apr 27, 2022
0
412
News tagged with prostate tumor
Oncology & Cancer
Cancer patients vulnerable to depression, suicide
Cancer can be a devastating diagnosis, and now two new studies show these patients are at increased risk for anxiety, depression and suicide.
Mar 29, 2022
0
80
Oncology & Cancer
Speeding up cancer biomarker detection for point of care diagnostics
The detection and quantification of cancer-associated molecular biomarkers in body fluids, or liquid biopsies, prove minimally invasive in early cancer diagnostics. Researchers at the University of Illinois Urbana-Champaign ...
Jan 28, 2022
0
63
Oncology & Cancer
Early prostate cancers can harbor aggressive tumor cells
Many cases of early prostate cancer are dominated by cells that are slow-growing, often leading to a clinical decision to monitor for progression before initiating treatments that can have adverse side effects.
Jan 19, 2022
0
0
Oncology & Cancer
Surgeons perform world's first precision prostatectomy with unique approach
Surgeons at Henry Ford Health System's Vattikuti Urology Institute (VUI) have performed what is believed to be the first precision prostatectomy through the bladder using a single port robotic surgical system.
Dec 13, 2021
0
25
Oncology & Cancer
Inherited mutation linked to aggressive prostate cancer
Men who inherit mutations in a gene called TP53 have a high risk of developing aggressive prostate cancer, a multicenter research team in the United States has found.
Dec 3, 2021
1
10
Oncology & Cancer
Prostate cancer organoids open path to precision oncology
A multi-institutional team of investigators led by bioengineer Ankur Singh has developed research tools that shed new light on a virtually untreatable form of prostate cancer, opening a pathway that may lead to novel therapeutics ...
Nov 24, 2021
0
16
Medications
New strategy against treatment-resistant prostate cancer identified
Many patients with prostate cancer are treated with drugs that lower or block hormones that fuel tumor growth. While the drugs are effective for a time, most patients eventually develop resistance to these therapies.
Nov 5, 2021
0
18
Oncology & Cancer
ATR inhibitor RP-3500 demonstrates safety and early clinical benefit
In a first-in-human, Phase I trial, researchers at The University of Texas MD Anderson Cancer Center discovered that ATR inhibitor RP-3500 was safe and well tolerated with promising clinical benefit. Principal investigator ...
Oct 8, 2021
0
29
Oncology & Cancer
Metastatic prostate cancer comes in two forms, which could guide treatment
Scientists have identified two subtypes of metastatic prostate cancer that respond differently to treatment, information that could one day guide physicians in treating patients with the therapies best suited to their disease.
Sep 23, 2021
0
9
